News at Geistlich Pharma AG

SubNavigation
2018 · 2017 · 2016 · 2015 · 2014 · 2013 ·
  • The foundation stone is laid for the “888plus” extension building at the Geistlich Pharma AG headquarters in Wolhusen. With this investment in the tens of millions, Geistlich demonstrates its commitment to its Switzerland location.

  • 35 percent better volume retention, improved soft tissue healing, even bone formation - Geistlich's xenogenic biomaterials clearly beat their allogenic competitors in a comparative study. A new brochure summarizes the highlights for the clinician.

  • Collect points, climb the ranking list, share and you can win a free registration to the International Osteology Symposium in Barcelona (25-27 April 2019).

  • Since all good things come in threes, after the success in 2016 and 2017, in 2018 Geistlich will once more offer a series of webinars presented by experts from around the world.

  • At the 2017 meeting of the American Academy of Periodontology (AAP) in Boston, the authors of the 2016 published article by Scheyer et al. with the title “A randomized, controlled, multicenter clinical trial of post-extraction alveolar ridge preservation” won the Clinical Research Award as an outstanding recently published scientific article with direct clinical relevance to periodontics. This study demonstrates that the combination Geistlich Bio-Oss® Collagen + Geistlich Bio-Gide® provides better soft tissue healing and ridge preservation for implant placement.

  • National "Future Day" was a busy time at Geistlich Pharma again this year. Around twenty girls and boys accompanied their parents to work on 9 November. In keeping with the slogan of “changing sides”, the children learned about gender-atypical careers and work areas. The highlight of the day offered something for everyone: going to the cleanroom visitors’ area and getting dressed up in genuine cleanroom suits was a good way of relaxing and having fun.

  • The 2017 EAO in Madrid with more than 4,000 participants was the perfect platform for the official launch of Geistlich Fibro-Gide®, the alternative to connective tissue grafts. Geistlich Biomaterials properly celebrated this event with its customers, paying tribute to 10 years of successful research.

  • On our blog: Dealing with peri-implantitis

    “The answer is education. We should all be able to diagnose and treat peri-implantitis”. With this statement, Prof. Stuart J. Froum, United States, summarizes his long-standing experience on this controversial topic in an interview on our blog www.regeneration-expert.com!

    > Read More

  • Soft-tissue management is the focus of the current issue of GEISTLICH NEWS. Once again outstanding experts shed light on this key topic in regenerative dentistry.

  • On our blog: Bisphosphonates: A contraindication for augmentations?

    Are bisphosphonates a contraindication for bone augmentation? Not all patients on anti-resorptive therapy have a high risk of osteonecrosis of the jaw. So, when is implantation possible, and what should a dentist consider? Prof. Bilal Al-Nawas, Germany, gives a thorough insight and shares his “dos and don’ts”. Discover more on our blog www.regeneration-expert.com!

    > Read More

PRESS CONTACT
Mirjam_Kessler_140x140.jpg
Dr. Mirjam Kessler
Director Corporate Communications
PRESS CONTACT
Verena.jpg
Verena Vermeulen
Scientific Communication Manager